Brad Siff
About Brad Siff
Brad Siff is the Founder and President of Biowave Corporation, where he has worked since 2000. He has a background in mergers and acquisitions and holds degrees in Mechanical Engineering and an MBA from Cornell University.
Work at Biowave
Brad Siff serves as the Founder and President of Biowave Corporation, a position he has held since 2000. Under his leadership, Biowave has developed innovative medical devices, including the BioWaveGO OTC device, which received FDA 510(k) clearance. Siff has secured a Federal Supply Schedule Contract with the U.S. Government for BioWave products and successfully negotiated contracts with major insurance companies such as Aetna and CIGNA to cover BioWave procedures. His efforts have contributed to the adoption of the BiowavePRO system by over 120 professional sports teams and 160 major college sports programs.
Education and Expertise
Brad Siff has a strong educational background with degrees from Cornell University. He earned a Bachelor of Science in Mechanical Engineering, followed by a Master of Engineering in Operations Research and Industrial Engineering. He also achieved an MBA from Cornell's Johnson Graduate School of Management, focusing on Entrepreneurship. His academic work includes a master's thesis on a special project for the Hospital for Special Surgery. This educational foundation supports his expertise in medical device development and business operations.
Background
Before founding Biowave, Brad Siff held significant roles in the finance sector. He worked at Daiwa Securities as Vice President of Mergers & Acquisitions from 1987 to 1993, eventually becoming Senior Vice President in the same department. His experience in finance and mergers has informed his approach to business development and strategic partnerships in the medical device industry. Additionally, he served as Chief Operating Officer at a prior medical device company, further enhancing his operational expertise.
Achievements
Brad Siff has achieved notable milestones in the medical device industry. He led the design and development of the BioWaveGO OTC device, which received FDA 510(k) clearance. He also achieved FDA 510(k) clearance for the BiowaveHOME Rx in just four weeks. Siff developed a noninvasive Tibial Nerve Stimulation system aimed at treating symptoms of overactive bladder and incontinence. His contributions have significantly impacted the adoption of Biowave products in both professional and collegiate sports.
Personal Interests
Outside of his professional endeavors, Brad Siff is a fitness enthusiast with interests in traveling, skiing, food, and wine. He enjoys playing tennis and paddle ball, reflecting his active lifestyle. Additionally, Siff is an artist and photographer, showcasing his creative side beyond the medical device industry.